BPO — Competitive Intelligence Brief

BPO (BPO) competitive landscape: 4 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Topical antimicrobial and keratolytic agent. Area: Dermatology.

marketed Topical antimicrobial and keratolytic agent Cutibacterium acnes (bacterial target); non-specific oxidative mechanism Dermatology Small molecule

Target snapshot

BPO (BPO) — Galderma R&D. BPO (benzoyl peroxide) kills acne-causing bacteria and reduces sebum production while promoting skin cell turnover.

Comparator set (4 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
BPO TARGET	BPO	Galderma R&D	marketed	Topical antimicrobial and keratolytic agent	Cutibacterium acnes (bacterial target); non-specific oxidative mechanism
ABPO Forte Gel	ABPO Forte Gel	Galderma R&D	marketed	Topical antimicrobial and keratolytic agent	Bacterial protein synthesis inhibition; mitochondrial oxidative stress in bacteria
Benzoyl peroxide 5% gel	Benzoyl peroxide 5% gel	University of Southern California	marketed	Topical antimicrobial and keratolytic agent
Benzoyl Peroxide Topical	Benzoyl Peroxide Topical	University of Missouri-Columbia	marketed	Topical antimicrobial and keratolytic agent
Benzoyl Peroxide 4 % Topical Cream	Benzoyl Peroxide 4 % Topical Cream	Pak Emirates Military Hospital	phase 3	Topical antimicrobial and keratolytic agent

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Topical antimicrobial and keratolytic agent class)

1. Galderma R&D · 2 drugs in this class
2. Pak Emirates Military Hospital · 1 drug in this class
3. University of Missouri-Columbia · 1 drug in this class
4. University of Southern California · 1 drug in this class